This Plain Language Summary of Publication article (PLSP) from Future Neurology, discusses iclepertin, an investigational medication being developed to treat cognitive symptoms in schizophrenia. Iclepertin (BI 425809) works as a glycine transporter 1 (GlyT1) inhibitor. The article also includes insights from patient advocate Carlos Larrauri, who shares his experience living with cognitive symptoms of schizophrenia.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia’ and was published in the European Archives of Psychiatry and Clinical Neuroscience.

Visit Springer Nature Link using the link to read the original article.